Purkiss Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Purkiss Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.27M	Buy	4,620 +466	+11%	+$253K	1%	26
2025 Q4	$2.41M	Sell	4,154 -324	-7%	-$183K	1.13%	18
2025 Q3	$2.17M	Buy	4,478 +1,023	+30%	+$476K	1.04%	21
2025 Q2	$1.4M	Buy	3,455 +1,186	+52%	+$496K	0.78%	27
2025 Q1	$1.13M	Buy	2,269 +114	+5%	+$61.7K	0.85%	23
2024 Q4	$1.12M	Buy	+2,155	New	+$1.18M	0.97%	22

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Purkiss Capital Advisors's TMO Position: Q1 2026 in Review

Purkiss Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, buying an estimated $253K and bringing the position to 4,620 shares worth $2.27M. The position accounts for 1% of the portfolio, ranked #26.

Purkiss Capital Advisors first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.41M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Purkiss Capital Advisors held 4,620 shares of Thermo Fisher Scientific worth $2.27M as of Q1 2026.
Purkiss Capital Advisors bought 466 Thermo Fisher Scientific shares in Q1 2026, an estimated $253K.
Thermo Fisher Scientific made up 1% of Purkiss Capital Advisors's portfolio in Q1 2026, its #26 holding.
Purkiss Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
Purkiss Capital Advisors's Thermo Fisher Scientific position peaked at $2.41M in Q4 2025.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Purkiss Capital Advisors's 13F filing for Q1 2026, filed 4 May 2026.